Overview

Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To demonstrate the bioequivalence of a Levetiracetam dry syrup (50% (500mg/1000mg)) versus Levetiracetam 500 mg oral tablet, used as reference, after single dose administration in healthy Japanese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam